Liver assay in liver spheroids for sirna/asos

Ended Purchase Order Awarded Last action

Contract number
75N95024P00430
Awardee
Awarding agency
Obligated
$90,414

Award facts

Opportunity
Contract value 100% obligated
$90,414.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
NAICS code
541380 Testing Laboratories and Services
PSC
B504 Special Studies/Analysis- Chemical/Biological
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Brunswick, ME 04011, USA

Award details come from SAM.gov/FPDS.

About this award

This is a $90,414 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, to Insphero Inc., a foreign-owned, for-profit manufacturer of 3D cell culture technologies and in vitro models. The contract is for a Liver Assay in Liver Spheroids to evaluate the toxicity of short interfering RNA (siRNA) and antisense oligonucleotides (ASOs), which are increasingly being used as individualized medicines. The objective is to generate proof-of-concept data using a 3D liver microtissue platform to predict the safety of future candidate siRNA/ASOs intended for clinical use. This is a non-competitive acquisition conducted under simplified acquisition procedures, with no set-aside designation. The period of performance is approximately 12 weeks from the award date of July 29, 2024.

Quick answers

Who was awarded contract 75N95024P00430?

75N95024P00430 was awarded to Insphero, Inc. by National Institute on Drug Abuse (National Institutes of Health) on July 29, 2024.

How much is contract 75N95024P00430 worth?

The government has obligated $90,414 on 75N95024P00430.

Which agency awarded contract 75N95024P00430?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024P00430, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Was contract 75N95024P00430 competed?

The extent of competition for 75N95024P00430 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award